BioArctic

Leqembi® Pen subcutaneous treatment launched in Japan

BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been…